Profil
Thomas J.
Marquez worked at Delsite, Inc. from 1987 to 2008, where he held the position of Director in 2008.
He also worked at Petrus Securities LP as the Head of Research.
Ehemalige bekannte Positionen von Thomas J. Marquez
| Unternehmen | Position | Ende |
|---|---|---|
Delsite, Inc.
 Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc. | Direktor/Vorstandsmitglied | 19.10.2008 |
Petrus Securities LP
 Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients. | Direktor der Forschung - Eigenkapital | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Petrus Securities LP
Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients. | Finance |
Delsite, Inc.
Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc. | Health Technology |
